AARD
AARD
NASDAQ · Pharmaceuticals

Aardvark Therapeutics Inc

$3.93
+0.11 (+2.88%)
As of Jun 21, 10:29 PM ET ·
Analyst Consensus
Buy
18
Analysts
High
Coverage
Buy 12 67%
Hold 4 22%
Sell 2 11%
Price Target
Analyst Price Target +567.7% upside
Low Target $21.03
Average Target $26.24
High Target $41.18
Current Price $3.93
Current
$3.93
Target
$26.24
$21.03 $26.24 avg $41.18
Scenario Analysis
Bear Case
$21.03
435.1%
Low target
Base Case
$26.24
+567.7%
Avg target
Bull Case
$41.18
+947.8%
High target
Risk/Reward
2.2x
Favorable
Price in Context
52-Week High
$17.94
-78.1% from high
52-Week Low
$3.35
+17.3% from low
Target vs 52W High
$26.24
+46.3% vs high
Peer Consensus — Pharmaceuticals
Stock Consensus Analysts Buy % Target Upside
LLY
Eli Lilly and Co.
Strong Buy 39 79% $1,330.33 +18.3%
RDY
Dr. Reddy's Laboratories
Sell 44 50% +0.0%
JNJ
Johnson & Johnson
Buy 31 68% $299.55 +22.2%
MRK
Merck & Co. Inc.
Buy 36 69% $159.27 +27.7%
PFE
Pfizer Inc.
Hold 36 42% $33.90 +42.3%
BMY
Bristol-Myers Squibb Co
Hold 36 39% $174.50 +217.3%
ZTS
Zoetis Inc
Buy 24 58% $209.87 +170.3%
RPRX
Royalty Pharma Plc- Cl A
Strong Buy 16 88% $36.26 -33.2%